SOUTH SAN FRANCISCO, CA, USA I 05, 2024 I Denali Therapeutics Inc. (Nasdaq: DNLI) today announced initiation of dosing in a global Phase 2a clinical ...
Concerns have been raised over patients facing long waits in emergency departments not being given time-sensitive medication after a man was left unable to swallow due to missed medicines. An elderly ...